Smith Paula, McGuffog Lesley, Easton Douglas F, Mann Graham J, Pupo Gulietta M, Newman Beth, Chenevix-Trench Georgia, Szabo Csilla, Southey Melissa, Renard Hélène, Odefrey Fabrice, Lynch Henry, Stoppa-Lyonnet Dominique, Couch Fergus, Hopper John L, Giles Graham G, McCredie Margaret R E, Buys Saundra, Andrulis Irene, Senie Ruby, Goldgar David E, Oldenburg Rogier, Kroeze-Jansema Karin, Kraan Jaennelle, Meijers-Heijboer Hanne, Klijn Jan G M, van Asperen Christi, van Leeuwen Inge, Vasen Hans F A, Cornelisse Cees J, Devilee Peter, Baskcomb Linda, Seal Sheila, Barfoot Rita, Mangion Jon, Hall Anita, Edkins Sarah, Rapley Elizabeth, Wooster Richard, Chang-Claude Jenny, Eccles Diana, Evans D Gareth, Futreal P Andrew, Nathanson Katherine L, Weber Barbara L, Rahman Nazneen, Stratton Michael R
CR-UK Genetic Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Genes Chromosomes Cancer. 2006 Jul;45(7):646-55. doi: 10.1002/gcc.20330.
Mutations in known breast cancer susceptibility genes account for a minority of the familial aggregation of the disease. To search for further breast cancer susceptibility genes, we performed a combined analysis of four genome-wide linkage screens, which included a total of 149 multiple case breast cancer families. All families included at least three cases of breast cancer diagnosed below age 60 years, at least one of whom had been tested and found not to carry a BRCA1 or BRCA2 mutation. Evidence for linkage was assessed using parametric linkage analysis, assuming both a dominant and a recessive mode of inheritance, and using nonparametric methods. The highest LOD score obtained in any analysis of the combined data was 1.80 under the dominant model, in a region on chromosome 4 close to marker D4S392. Three further LOD scores over 1 were identified in the parametric analyses and two in the nonparametric analyses. A maximum LOD score of 2.40 was found on chromosome arm 2p in families with four or more cases of breast cancer diagnosed below age 50 years. The number of linkage peaks did not differ from the number expected by chance. These results suggest regions that may harbor novel breast cancer susceptibility genes. They also indicate that no single gene is likely to account for a large fraction of the familial aggregation of breast cancer that is not due to mutations in BRCA1 or BRCA2.
已知乳腺癌易感基因的突变仅占该疾病家族聚集性的一小部分。为了寻找更多的乳腺癌易感基因,我们对四项全基因组连锁筛查进行了联合分析,这些筛查共纳入了149个多病例乳腺癌家族。所有家族至少有三例60岁以下确诊的乳腺癌病例,其中至少有一例已接受检测且未发现携带BRCA1或BRCA2突变。使用参数连锁分析评估连锁证据,假设遗传模式为显性和隐性,并使用非参数方法。在联合数据的任何分析中,在4号染色体上靠近标记D4S392的区域,显性模型下获得的最高LOD分数为1.80。在参数分析中还发现了另外三个超过1的LOD分数,在非参数分析中发现了两个。在50岁以下确诊四例或更多乳腺癌病例的家族中,在2号染色体短臂上发现了最高LOD分数2.40。连锁峰的数量与偶然预期的数量没有差异。这些结果表明了可能含有新型乳腺癌易感基因的区域。它们还表明,没有单个基因可能导致很大一部分并非由BRCA1或BRCA2突变引起的乳腺癌家族聚集性。